Zenas Biopharma Inc (NASDAQ: ZBIO) kicked off on Monday, down -19.71% from the previous trading day, before settling in for the closing price of $40.59. Over the past 52 weeks, ZBIO has traded in a range of $5.83-$41.50.
While this was happening, its average annual earnings per share was recorded 65.99%. With a float of $21.93 million, this company’s outstanding shares have now reached $42.21 million.
Zenas Biopharma Inc (ZBIO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Zenas Biopharma Inc is 59.14%, while institutional ownership is 31.11%. The most recent insider transaction that took place on Oct 09 ’25, was worth 1,200,002. In this transaction Director of this company bought 63,158 shares at a rate of $19.00, taking the stock ownership to the 1,173,395 shares. Before that another transaction happened on Oct 09 ’25, when Company’s 10% Owner bought 126,315 for $19.00, making the entire transaction worth $2,399,985. This insider now owns 1,917,895 shares in total.
Zenas Biopharma Inc (ZBIO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 65.99% per share during the next fiscal year.
Zenas Biopharma Inc (NASDAQ: ZBIO) Trading Performance Indicators
Take a look at Zenas Biopharma Inc’s (ZBIO) current performance indicators. Last quarter, stock had a quick ratio of 5.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 116.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.53, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -4.26 in one year’s time.
Technical Analysis of Zenas Biopharma Inc (ZBIO)
Looking closely at Zenas Biopharma Inc (NASDAQ: ZBIO), its last 5-days average volume was 0.31 million, which is a jump from its year-to-date volume of 0.25 million. As of the previous 9 days, the stock’s Stochastic %D was 60.14%.
During the past 100 days, Zenas Biopharma Inc’s (ZBIO) raw stochastic average was set at 67.61%, which indicates a significant increase from 10.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.15 in the past 14 days, which was higher than the 2.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.27, while its 200-day Moving Average is $17.45. However, in the short run, Zenas Biopharma Inc’s stock first resistance to watch stands at $38.62. Second resistance stands at $44.66. The third major resistance level sits at $48.21. If the price goes on to break the first support level at $29.03, it is likely to go to the next support level at $25.48. Now, if the price goes above the second support level, the third support stands at $19.44.
Zenas Biopharma Inc (NASDAQ: ZBIO) Key Stats
The company with the Market Capitalisation of 1.75 billion has total of 53,679K Shares Outstanding. Its annual sales at the moment are 5,000 K in contrast with the sum of -156,990 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -52,220 K.
